SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Return
29.51%
This Quarter Return
+9.67%
1 Year Return
+29.51%
3 Year Return
+13.62%
5 Year Return
+117.76%
10 Year Return
+239.6%
AUM
$1.11B
AUM Growth
+$157M
(+16%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
10.88%
Top 10 Holdings %
Top 10 Hldgs %
6.94%
Holding
994
New
329
Increased
197
Reduced
157
Closed
311
Top Buys
| 1 |
TSMC
TSM
|
$8.64M |
| 2 |
McKesson
MCK
|
$7.73M |
| 3 |
Reddit
RDDT
|
$7.62M |
| 4 |
Global Payments
GPN
|
$7.35M |
| 5 |
Palantir
PLTR
|
$7.28M |
Top Sells
| 1 |
Spotify
SPOT
|
$9.68M |
| 2 |
Infosys
INFY
|
$7.42M |
| 3 |
Upstart Holdings
UPST
|
$6.7M |
| 4 |
Lyft
LYFT
|
$6.33M |
| 5 |
American Airlines Group
AAL
|
$6.12M |
Sector Composition
| 1 | Technology | 18.3% |
| 2 | Healthcare | 15.73% |
| 3 | Financials | 13.72% |
| 4 | Industrials | 13.51% |
| 5 | Consumer Discretionary | 13.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Radian Group
RDN
$4.79B
| $831K | 0.07% |
23,960
+12,912
| +117% | +$448K |
|
452
ZTO Express
ZTO
$14.7B
| $826K | 0.07% |
+33,355
| New | +$826K |
|
453
Myriad Genetics
MYGN
$615M
| $821K | 0.07% |
29,960
+20,298
| +210% | +$556K |
|
454
Nu Holdings
NU
$71.2B
| $820K | 0.07% |
+60,047
| New | +$820K |
|
455
Asana
ASAN
$3.18B
| $816K | 0.07% |
70,425
+52,380
| +290% | +$607K |
|
456
Illinois Tool Works
ITW
$77.6B
| $813K | 0.07% |
+3,103
| New | +$813K |
|
457
CRH
CRH
$75.4B
| $812K | 0.07% |
8,759
-39,886
| -82% | -$3.7M |
|
458
Arcosa
ACA
$4.79B
| $807K | 0.07% |
+8,518
| New | +$807K |
|
459
Flowers Foods
FLO
$3.13B
| $806K | 0.07% |
34,954
+24,221
| +226% | +$559K |
|
460
Kinetik
KNTK
$2.58B
| $806K | 0.07% |
+17,804
| New | +$806K |
|
461
First Bancorp
FBP
$3.54B
| $793K | 0.07% |
+37,476
| New | +$793K |
|
462
Church & Dwight Co
CHD
$23.3B
| $793K | 0.07% |
+7,576
| New | +$793K |
|
463
Jackson Financial
JXN
$6.65B
| $791K | 0.07% |
+8,671
| New | +$791K |
|
464
Avient
AVNT
$3.45B
| $787K | 0.07% |
+15,643
| New | +$787K |
|
|
ITCI
465
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $786K | 0.07% |
10,742
-11,168
| -51% | -$817K |
|
466
Saic
SAIC
$4.83B
| $770K | 0.07% |
+5,531
| New | +$770K |
|
467
Abbott
ABT
$231B
| $768K | 0.07% |
6,732
-33,118
| -83% | -$3.78M |
|
468
Thomson Reuters
TRI
$78.7B
| $766K | 0.07% |
4,489
-6,076
| -58% | -$1.04M |
|
469
Generac Holdings
GNRC
$10.6B
| $763K | 0.07% |
+4,802
| New | +$763K |
|
470
XPO
XPO
$15.4B
| $762K | 0.07% |
7,091
-7,027
| -50% | -$755K |
|
471
Fabrinet
FN
$13.2B
| $759K | 0.07% |
3,212
-1,181
| -27% | -$279K |
|
472
La-Z-Boy
LZB
$1.49B
| $759K | 0.07% |
+17,685
| New | +$759K |
|
473
Loews
L
$20B
| $759K | 0.07% |
9,603
+6,582
| +218% | +$520K |
|
474
Teva Pharmaceuticals
TEVA
$21.7B
| $753K | 0.07% |
41,779
-43,375
| -51% | -$782K |
|
475
Kyndryl
KD
$7.57B
| $750K | 0.07% |
+32,622
| New | +$750K |
|